Peptides for Biohackers: What's Actually Evidence-Backed in the Longevity Space
Honest evidence assessment of the longevity peptides that dominate biohacker protocols: Epitalon, MOTS-c, SS-31, GHK-Cu, FOXO4-DRI, and the Khavinson bioregulators.
How peptide Targets Peptides for Biohackers & Longevity Protocols
The longevity-peptide landscape has more advocacy than evidence. The honest framing for any of these compounds is that they sit somewhere on a spectrum from 'biologically interesting with thin clinical data' to 'biologically interesting with almost no human data'. None of them have completed a longevity-endpoint RCT in humans, because longevity-endpoint trials in humans are a multi-decade undertaking nobody has funded.
Closest to evidence-supported: GHK-Cu has decades of dermatology and wound-healing data. Its mechanism is real (modulates >4,000 genes), and the cosmetic translation is well-supported. Whether topical or systemic GHK-Cu produces measurable systemic longevity benefit is not established.
Reasonable mechanistic case, thin clinical data: Epitalon has the longest 'longevity peptide' history. Khavinson's group has published cohort data suggesting reduced mortality and cancer incidence in elderly Russian populations on cyclic Epitalon. External replication of those endpoints is essentially absent. Mechanistic premise (telomerase activation, melatonin restoration) is biologically plausible.
MOTS-c and the mitochondrial-derived peptide class have a 'metabolic flexibility' rationale grounded in mtDNA-encoded signaling. Most data is rodent. SS-31 (elamipretide) has more clinical depth in mitochondrial disease but isn't really studied in healthy adults pursuing longevity.
More speculative: FOXO4-DRI is a senolytic peptide with rodent evidence for selective elimination of senescent cells. There is no published human safety or efficacy trial. Use is exploratory.
Where biohackers most often go wrong: stacking 5+ peptides simultaneously and attributing every subjective change to the peptide stack rather than the diet, sleep, and training shifts that usually accompany the experiment. Simple protocols with one variable at a time generate interpretable data; complex stacks generate stories.
Recommended Peptides (10)
5-Amino-1MQ
Research-Grade
A small-molecule NNMT inhibitor (technically not a peptide) grouped with peptides in fat-loss contexts, investigated in preclinical obesity and muscle-aging models.
Epitalon
Research-Grade
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on pineal extract Epithalamin — studied by Russian researchers for telomerase, circadian, and longevity endpoints.
FOXO4-DRI
Research-Grade
A D-retro-inverso peptide that disrupts FOXO4-p53 interactions in senescent cells, triggering selective apoptosis. The first peptide-based senolytic — published in Cell (2017) with striking mouse healthspan data.
GHK-Cu (Copper Tripeptide-1)
Cosmetic-Grade
A naturally occurring copper-binding tripeptide (Gly-His-Lys) with decades of cosmetic dermatology research in wound healing and skin remodeling.
Humanin
Research-Grade
A 24-amino-acid mitochondrial-derived peptide (MDP) with cytoprotective, anti-apoptotic, and neuroprotective activity. Encoded within the mitochondrial genome, humanin represents a new class of retrograde signaling molecules.
MOTS-c
Research-Grade
A 16-amino-acid peptide encoded in the mitochondrial 12S rRNA — investigated as a metabolic regulator of AMPK signaling and insulin sensitivity.
Sermorelin
Research-Grade
The first synthetic GHRH analog approved for clinical use — GHRH (1-29) NH₂, the minimum active sequence. Shorter-acting than tesamorelin or CJC-1295.
SS-31 (Elamipretide)
Research-Grade
A cell-permeable tetrapeptide that targets the inner mitochondrial membrane, stabilizing cardiolipin and improving electron transport chain efficiency — in late-stage clinical trials for mitochondrial and cardiac diseases.
Thymalin
Research-Grade
A thymic peptide bioregulator developed by the St. Petersburg Institute of Bioregulation and Gerontology, studied in Russian clinical cohorts for immune reconstitution and longevity.
Thymosin α1
Zadaxin
A 28-amino-acid thymic peptide approved in 30+ countries (not US) for hepatitis B/C and as an immune adjunct in oncology and infectious disease.
Frequently Asked Questions
Which longevity peptide has the strongest human evidence?
Are stacks like 'Wolverine' or 'Klow' actually synergistic?
Should I cycle Epitalon?
Is FOXO4-DRI safe to self-experiment with?
What labs should I track on a longevity peptide protocol?
Should I rely on peptides over rapamycin/metformin/NAD precursors for longevity?
Other peptide Skin Concerns
Peptides for Acne Scars
Topical and systemic peptides that address the collagen disruption, inflammation, and pigmentation c…
Peptides for Anti-Aging
Anti-aging is the loosest indication in the peptide literature. 'Longevity' claims are typically ove…
Peptides for Athletes & Endurance Training
Which peptides actually have evidence for athletic recovery, what's on the WADA prohibited list, and…
Peptides for Brain Fog & Cognitive Clarity
Brain fog — the subjective experience of reduced mental clarity, focus, and processing speed — has m…
Peptides for Cognitive Function
The cognitive peptide space is dominated by Russian-developed compounds (Semax, Selank, Cerebrolysin…
Peptides for Type 2 Diabetes
GLP-1 receptor agonists are now the most important drug class in T2D management. Here's the evidence…
Peptides for Fat Loss
The peptide conversation around fat loss has shifted entirely since the GLP-1 era. This page separat…
Peptides for Gut Health
BPC-157 dominates the gut-health peptide conversation, but the evidence is almost entirely preclinic…
Peptides for Hair Growth
The peptide hair-growth literature is dominated by GHK-Cu topical and copper peptide complexes. Sign…
Peptides for Immune Support
Thymosin Alpha-1 is the strongest-evidence immune peptide, with international marketing authorizatio…
Peptides for Injury Recovery
The regenerative peptide category — BPC-157, TB-500, GHK-Cu — has more preclinical signal than most …
Peptides for Longevity
Longevity peptides carry the most hype-to-evidence gap in the field. Russian bioregulator peptides (…
Peptides for Men Over 40
Testosterone decline, recovery debt, and visceral fat accumulation drive peptide selection past 40. …
Peptides for Metabolic Optimization
Metabolic peptides overlap heavily with fat-loss peptides but emphasize different endpoints: insulin…
Peptides for Muscle Growth
Hypertrophy-focused peptide protocols cluster around two axes: GH-axis amplification and direct anab…
Peptides for PCOS
Polycystic ovary syndrome combines insulin resistance, hyperandrogenism, and disrupted LH/FSH signal…
Peptides for Post-Cycle Therapy & HPG Axis Recovery
Gonadorelin, Kisspeptin-10, GHRH analogs in PCT protocols. What's mechanistically real, what's marke…
Peptides After Bariatric Surgery
Bariatric surgery (Roux-en-Y bypass, sleeve gastrectomy, duodenal switch) changes peptide pharmacoki…
Peptides After Menopause
Bone density, body composition, cardiovascular shift, and skin aging change peptide selection after …
Peptides for Post-Surgery Recovery
Surgical recovery creates a defined healing window where peptide interventions are most biologically…
Peptides for Sexual Health
Bremelanotide (Vyleesi) is the only FDA-approved peptide for sexual dysfunction — specifically HSDD …
Peptides for Skin & Glow
Cosmetic peptides have decades of dermatology research. GHK-Cu, Matrixyl, Argireline, and polynucleo…
Peptides for Sleep
The peptide-for-sleep conversation is thinner than marketing implies. DSIP is the only dedicated sle…
Peptides for Women Over 40
Hormonal transition, collagen decline, and metabolic shift change which peptides are sensible past 4…